tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AU:NOX Stock Latest News

Noxopharm Clears Key Safety Milestone as HERACLES Trial Concludes and Sofra Platform Gains Global Traction
Company AnnouncementsNoxopharm Clears Key Safety Milestone as HERACLES Trial Concludes and Sofra Platform Gains Global Traction
8d ago
NOX
Noxopharm Clears Safety Milestone as HERACLES Trial for SOF-SKN Concludes
PremiumCompany Announcements
Noxopharm Clears Safety Milestone as HERACLES Trial for SOF-SKN Concludes
17d ago
NOX
Noxopharm Rolls Over $2.6m in Convertible Notes, Flagging Potential Share Dilution
PremiumCompany Announcements
Noxopharm Rolls Over $2.6m in Convertible Notes, Flagging Potential Share Dilution
1M ago
NOX
Noxopharm Issues New Unquoted Options and Convertible Notes
PremiumCompany Announcements
Noxopharm Issues New Unquoted Options and Convertible Notes
1M ago
NOX
Noxopharm Redeems 2.6 Million Convertible Notes, Trimming Convertible Debt
PremiumCompany Announcements
Noxopharm Redeems 2.6 Million Convertible Notes, Trimming Convertible Debt
1M ago
NOX
Noxopharm Ltd. Announces Director’s Interest Change
PremiumCompany AnnouncementsNoxopharm Ltd. Announces Director’s Interest Change
2M ago
NOX
Noxopharm Issues Convertible Notes to Restructure Capital
Premium
Company Announcements
Noxopharm Issues Convertible Notes to Restructure Capital
2M ago
NOX
Noxopharm Ltd. Issues New Equity Securities to Bolster Growth
Premium
Company Announcements
Noxopharm Ltd. Issues New Equity Securities to Bolster Growth
2M ago
NOX
Noxopharm Advances SOF-SKN™ Clinical Trial for Autoimmune Diseases
PremiumCompany Announcements
Noxopharm Advances SOF-SKN™ Clinical Trial for Autoimmune Diseases
2M ago
NOX
Noxopharm’s AGM Resolutions Passed, Highlighting Growth Potential of Sofra Platform
PremiumCompany Announcements
Noxopharm’s AGM Resolutions Passed, Highlighting Growth Potential of Sofra Platform
3M ago
NOX
Noxopharm Unveils 2025 AGM Presentation, Showcasing Clinical and Market Advancements
PremiumCompany Announcements
Noxopharm Unveils 2025 AGM Presentation, Showcasing Clinical and Market Advancements
3M ago
NOX
Noxopharm Advances Sofra™ Platform with Promising Clinical Trials
PremiumCompany Announcements
Noxopharm Advances Sofra™ Platform with Promising Clinical Trials
3M ago
NOX
Noxopharm Advances HERACLES Trial with SOF-SKN Dosing
PremiumCompany AnnouncementsNoxopharm Advances HERACLES Trial with SOF-SKN Dosing
3M ago
NOX
Noxopharm and UNSW Sydney Collaborate on Inflammation Study with Government Grant
Premium
Company Announcements
Noxopharm and UNSW Sydney Collaborate on Inflammation Study with Government Grant
3M ago
NOX
Noxopharm Advances HERACLES Trial for Autoimmune Drug SOF-SKN
Premium
Company Announcements
Noxopharm Advances HERACLES Trial for Autoimmune Drug SOF-SKN
3M ago
NOX
Noxopharm Advances Sofra Platform with New Collaborations and Promising Trial Results
PremiumCompany Announcements
Noxopharm Advances Sofra Platform with New Collaborations and Promising Trial Results
3M ago
NOX
Noxopharm’s SOF-SKN Study: A Potential Game-Changer in Dermatology
PremiumCompany Announcements
Noxopharm’s SOF-SKN Study: A Potential Game-Changer in Dermatology
3M ago
NOX
Noxopharm Secures First US Patent for Sofra™ Technology in Cancer Treatment
PremiumCompany Announcements
Noxopharm Secures First US Patent for Sofra™ Technology in Cancer Treatment
4M ago
NOX
Noxopharm Limited Announces 2025 AGM Details and Key Resolutions
PremiumCompany Announcements
Noxopharm Limited Announces 2025 AGM Details and Key Resolutions
4M ago
NOX
Noxopharm Advances Clinical Trials, Boosts Stakeholder Interest
PremiumCompany AnnouncementsNoxopharm Advances Clinical Trials, Boosts Stakeholder Interest
4M ago
NOX
Noxopharm Releases FY2025 Governance Documents
Premium
Company Announcements
Noxopharm Releases FY2025 Governance Documents
4M ago
NOX
Noxopharm Advances Drug Development with New Trials and Strategic Partnerships
Premium
Company Announcements
Noxopharm Advances Drug Development with New Trials and Strategic Partnerships
4M ago
NOX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >